We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MannKind Sees Positive Phase III Results for New Insulin Inhaler
MannKind Sees Positive Phase III Results for New Insulin Inhaler
August 14, 2013
MannKind says two Phase III trials of its next generation insulin inhaler, an alternative to shots and oral drugs, showed it to be significantly better than standard treatments for diabetic patients.